Boehringer Ingelheim refines its bioprocess technology operations in Animal Health with greater focus on environmental sustainability to reduce footprint.
Dr. Hugh Marston and Dr. Vikas Mohan Sharma discuss what precision psychiatry entails and how it can enable people living with mental health conditions to thrive.
The Boehringer Ingelheim Venture Fund (BIVF) acquires minority stakes in biotech start-ups exploring promising therapies and technologies, and even supports the majority before and during their founding.
By working with a range of stakeholders, including patients, advocacy organizations, researchers, academics and more, we can make a meaningful impact in transforming the lives of people with cancer.
Hope for the future of interstitial lung disease (ILD) care
Karen Moor, pulmonologist in training and post-doctoral researcher in interstitial lung diseases (ILDs), shares her advice for aspiring pulmonologists and her hopes for the future of ILD care.